Five recent CRISPR drug target discoveries
This article highlights five of the latest findings revealed using CRISPR that could be used in the development or design of new therapies.
List view / Grid view
This article highlights five of the latest findings revealed using CRISPR that could be used in the development or design of new therapies.
Frameshifting therapy has been shown to reduce the number of mast cells by “mutating” mRNA, showing promise as a new cancer treatment.
A team have developed a minimally invasive exosome spray that helped repair rat hearts after myocardial infarction.
Lung spheroid cells can act as nanodecoys for the SARS-CoV-2 Spike protein to bind to, according to a new pre-clinical study.
Scientists have discovered that manipulating residues enables precision during the antibiotic biosynthesis assembly line.
A team has shown that tilorone, quinacrine and pyronaridine are effective at inhibiting the replication of SARS-CoV-2 in vitro.
Researchers have revealed that the microRNA miR-218-5p promoted hair growth in mice, so is a promising drug target for hair loss.
Researchers have shown that CRISPR-Cas3 can successfully attack C. difficile in vitro and in mice, by causing DNA damage to the pathogen.
Rodent models of pulmonary fibrosis have been used to show that lung spheroid cell secretome therapy is as effective as stem cell secretome treatment.
In a study, researchers have developed a biosensor concept using organs-on-a-chip to measure the levels of oxygen in real-time...
Prenatal exposure to BPA affects gene expression related to sexual differentiation and neurodevelopment in the developing brain...
Researchers have developed a high-throughput technique that can determine if a chemical has the potential to activate key genes in seconds...